The available database comprises research projects in Fisheries, Aquaculture, Seafood Processing and Marine Biotechnology active in the time period 2003-2022.
BlueBio is an ERA-NET COFUND created to directly identify new and improve existing ways of bringing bio-based products and services to the market and find new ways of creating value from in the blue bioeconomy.

More information on the BlueBio project and participating funding organizations is available on the BlueBio website: www.bluebioeconomy.eu

Last Update: 2024/06/19

NA
Marine Biotechnology
Aquaculture
Tenacibaculum spp. causing ulcers in farmed Atlantic salmon
National Programme
National
Henrik Duesund
NA
NA
NA
2014
2018
€ 179,400
https://prosjektbanken.forskningsradet.no/project/FORISS/241364?Kilde=FORISS&distribution=Ar&chart=bar&calcType=funding&Sprak=no&sortBy=date&sortOrder=desc&resultCount=30&offset=960&Departement=Landbruks-+og+matdepartementet&source=FORISS&projectId=296413
Skin ulcers have been a major disease problem in the production of Atlantic salmon in Norway. Cermaq has experienced high mortality and downgrading at harvest due to Tenacibaculum spp. Infections. There is little public research on this topic, so Cermaq established a research project in 2013 to build knowledge about Tenacibaculum spp. Infections, and to develop preventative measures. This project included two master thesis studies at the University of Bergen. The preliminary findings in these studies sho wed by a pilot challenge study, that we were able to reproduce the disease seen in the field. In addition this pilot study showed indications of a new species in the genus Tenacibaculum, that needs to be described. The main goal of this project "Tenaciba culum spp. Causing ulcers in farmed Atlantic salmon" is to gain more knowledge about Tenacibaculum spp. and infections with this bacterium and develop preventive measures to reduce impact in salmon farming. This will be done by standardizing the infection model to be able to do vaccine tests and measure antibody response in infected fish to see if vaccination could be a solution. The bacteria will also be described as a species using traditional methods, but in addition a full genome sequence has and will be used to look at Multi Locus Sequence Typing (MLST) and Various Number of Tandem Repeats (vNTR). An antibody response test will be carried out by developing a low tech vaccine candidate and running a vaccine trial. This will allow us to investigate if a vaccine could be solution in the future. It will also be important to attempt to find the marine reservoir of the bacteria and try to find the infection routs. This will be done by using a real time RT-PCR assay developed in the pilot study. The knowled ge obtained in the characterization will be important in this work.
Genomic sequencing; Bacteria; Disease; Vaccines development; Fish; Genetic; Salmon;
Not associated to marine areas
map png
If there is any incorrect or missing information on this project please access here or contact bluebio.database@irbim.cnr.it
/* */